Teleflex Incorporated (TFX) Director Benson Smith Sells 9,331 Shares

Teleflex Incorporated (NYSE:TFX) Director Benson Smith sold 9,331 shares of the company’s stock in a transaction dated Monday, October 8th. The shares were sold at an average price of $250.31, for a total value of $2,335,642.61. Following the completion of the transaction, the director now owns 77,887 shares in the company, valued at approximately $19,495,894.97. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Benson Smith also recently made the following trade(s):

  • On Monday, September 17th, Benson Smith sold 9,331 shares of Teleflex stock. The shares were sold at an average price of $266.73, for a total value of $2,488,857.63.
  • On Monday, August 27th, Benson Smith sold 9,331 shares of Teleflex stock. The shares were sold at an average price of $247.69, for a total value of $2,311,195.39.
  • On Monday, August 6th, Benson Smith sold 9,331 shares of Teleflex stock. The shares were sold at an average price of $241.84, for a total value of $2,256,609.04.
  • On Monday, July 16th, Benson Smith sold 9,331 shares of Teleflex stock. The shares were sold at an average price of $272.07, for a total value of $2,538,685.17.

NYSE:TFX opened at $248.00 on Thursday. Teleflex Incorporated has a 52 week low of $227.52 and a 52 week high of $288.78. The company has a market capitalization of $12.19 billion, a P/E ratio of 29.52, a PEG ratio of 1.87 and a beta of 1.12. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.45 and a current ratio of 2.21.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, August 2nd. The medical technology company reported $2.47 EPS for the quarter, topping analysts’ consensus estimates of $2.41 by $0.06. Teleflex had a return on equity of 17.32% and a net margin of 3.78%. The firm had revenue of $609.87 million for the quarter, compared to the consensus estimate of $615.97 million. During the same quarter in the prior year, the company posted $2.04 earnings per share. The firm’s revenue was up 15.4% on a year-over-year basis. On average, sell-side analysts anticipate that Teleflex Incorporated will post 9.82 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 14th. Investors of record on Wednesday, August 15th were issued a $0.34 dividend. The ex-dividend date of this dividend was Tuesday, August 14th. This represents a $1.36 dividend on an annualized basis and a yield of 0.55%. Teleflex’s dividend payout ratio is currently 16.19%.

A number of research firms recently commented on TFX. ValuEngine upgraded Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, September 13th. Needham & Company LLC dropped their price objective on Teleflex from $298.00 to $279.00 and set a “buy” rating on the stock in a report on Friday, August 3rd. TheStreet downgraded Teleflex from a “b” rating to a “c+” rating in a report on Friday, August 3rd. Finally, Morgan Stanley dropped their price objective on Teleflex from $310.00 to $295.00 and set an “overweight” rating on the stock in a report on Friday, August 3rd. Two investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $289.25.

A number of large investors have recently added to or reduced their stakes in the stock. Hsbc Holdings PLC boosted its position in Teleflex by 11.4% during the first quarter. Hsbc Holdings PLC now owns 5,329 shares of the medical technology company’s stock worth $1,359,000 after purchasing an additional 546 shares during the period. Asset Management One Co. Ltd. boosted its position in Teleflex by 1.4% during the first quarter. Asset Management One Co. Ltd. now owns 83,855 shares of the medical technology company’s stock worth $21,382,000 after purchasing an additional 1,143 shares during the period. Northwestern Mutual Investment Management Company LLC boosted its position in Teleflex by 56.2% during the first quarter. Northwestern Mutual Investment Management Company LLC now owns 9,218 shares of the medical technology company’s stock worth $2,350,000 after purchasing an additional 3,318 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp boosted its position in Teleflex by 2.4% during the first quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 16,932 shares of the medical technology company’s stock worth $4,317,000 after purchasing an additional 389 shares during the period. Finally, Lord Abbett & CO. LLC boosted its position in Teleflex by 1,245.2% during the first quarter. Lord Abbett & CO. LLC now owns 188,325 shares of the medical technology company’s stock worth $48,019,000 after purchasing an additional 174,325 shares during the period. Hedge funds and other institutional investors own 88.89% of the company’s stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.

Read More: Stop Order Uses For Individual Investors

Insider Buying and Selling by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply